Evidence mapPaperPMID 39764551Full record

ArticleFrontiers in medicine2024

Editorial: Tumor microenvironment and beyond: imaging systemic immunity with PET.

Jelena Levi, Israt S Alam, Tomomi W Nobashi

Abstract readEditorial
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advancing In Vivo Detection of T-Cell Function: Development and Preclinical Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jelena LeviCellSight Technologies, Inc., San Francisco, CA, United States.
Israt S AlamMolecular Imaging Program at Stanford, Department of Radiology, School of Medicine, Stanford University, Stanford, CA, United States.
Tomomi W NobashiPreemptive Medicine and Lifestyle Related Disease Research Center, Kyoto University Hospital, Kyoto, Japan.

Funding

Developing clinically relevant PET tracers to image T cell activation for improved cancer immunotherapy monitoringR01CA286998 · STANFORD UNIVERSITY · 2025 to 2025
$535k
NCI NIH HHS R01 CA286998
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

imaging biomarkersimaging checkpoint inhibitor therapyimaging immunotherapy responseimaging T cellsimmune-related adverse eventPET imaging of systemic immunity

Identifiers

PMID39764551
PMCPMC11701234

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.